{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T10:54:06Z","timestamp":1793271246430,"version":"4.5.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.cllc.2013.09.001","type":"journal-article","created":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T01:31:20Z","timestamp":1384306280000},"page":"7-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Altered Glutamine Metabolism and Therapeutic Opportunities for Lung Cancer"],"prefix":"10.1016","volume":"15","author":[{"given":"Amr","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadlo R.","family":"Khuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taofeek K.","family":"Owonikoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2013.09.001_bib1","first-page":"91","article-title":"Lung cancer: new biological insights and recent therapeutic advances","volume":"61","author":"Ramalingam","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cllc.2013.09.001_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/01243894-200601000-00014","article-title":"PET scan in lung cancer: current recommendations and innovation","volume":"1","author":"Vansteenkiste","year":"2006","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2013.09.001_bib3","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1158\/1078-0432.CCR-12-2587","article-title":"Targeting cancer metabolism","volume":"18","author":"Teicher","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2013.09.001_bib4","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1126\/science.1188015","article-title":"Evidence for an alternative glycolytic pathway in rapidly proliferating cells","volume":"329","author":"Vander Heiden","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.cllc.2013.09.001_bib5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ccr.2012.09.020","article-title":"Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth","volume":"22","author":"Hitosugi","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cllc.2013.09.001_bib6","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1158\/0008-5472.CAN-09-3556","article-title":"Rethinking the Warburg effect with Myc micromanaging glutamine metabolism","volume":"70","author":"Dang","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2013.09.001_bib7","doi-asserted-by":"crossref","first-page":"10551","DOI":"10.1021\/jm301191p","article-title":"Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES) analogs as glutaminase inhibitors","volume":"55","author":"Shukla","year":"2012","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.cllc.2013.09.001_bib8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1152\/jappl.1974.36.6.693","article-title":"Intracellular free amino acid concentration in human muscle tissue","volume":"36","author":"Bergstrom","year":"1974","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.cllc.2013.09.001_bib9","first-page":"600","article-title":"Adaptive regulation in skeletal muscle\u00a0glutamine metabolism in endotoxin-treated rats","volume":"32","author":"Austgen","year":"1992","journal-title":"J\u00a0Trauma"},{"key":"10.1016\/j.cllc.2013.09.001_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00230880","article-title":"Relevance of glutamine metabolism to tumor cell growth","volume":"113","author":"Medina","year":"1992","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.cllc.2013.09.001_bib11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1177\/0148607187011006569","article-title":"Interorgan ammonia metabolism in health and disease: a surgeon's view","volume":"11","author":"Souba","year":"1987","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.cllc.2013.09.001_bib12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1590\/S0100-879X2003000200002","article-title":"Glutamine and glutamate as vital metabolites","volume":"36","author":"Newsholme","year":"2003","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.cllc.2013.09.001_bib13","first-page":"2068S","article-title":"Interorgan amino acid transport and its regulation","volume":"133","author":"Brosnan","year":"2003","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.cllc.2013.09.001_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1083\/jcb.200703099","article-title":"Deficiency in glutamine but not glucose\u00a0induces MYC-dependent apoptosis in human cells","volume":"178","author":"Yuneva","year":"2007","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.cllc.2013.09.001_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ki.1982.142","article-title":"The kidney of chicken adapts to chronic metabolic acidosis: in\u00a0vivo and in\u00a0vitro studies","volume":"22","author":"Craan","year":"1982","journal-title":"Kidney Int"},{"key":"10.1016\/j.cllc.2013.09.001_bib16","doi-asserted-by":"crossref","first-page":"26421","DOI":"10.1074\/jbc.273.41.26421","article-title":"Overexpression of protein targeting to glycogen (PTG) in rat hepatocytes causes profound activation of glycogen synthesis independent of normal hormone- and substrate-mediated regulatory mechanisms","volume":"273","author":"Berman","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cllc.2013.09.001_bib17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0968-0004(93)90109-Z","article-title":"On target with a new mechanism for the regulation of protein phosphorylation","volume":"18","author":"Hubbard","year":"1993","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.cllc.2013.09.001_bib18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1146\/annurev.bi.52.070183.003431","article-title":"Glutathione","volume":"52","author":"Meister","year":"1983","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.cllc.2013.09.001_bib19","first-page":"1969s","article-title":"Glutathione, ascorbate, and cellular protection","volume":"54","author":"Meister","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2013.09.001_bib20","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00000658-199312000-00004","article-title":"Glutamine and cancer","volume":"218","author":"Souba","year":"1993","journal-title":"Ann Surg"},{"key":"10.1016\/j.cllc.2013.09.001_bib21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1126\/science.122.3168.501","article-title":"Nutrition needs of mammalian cells in tissue culture","volume":"122","author":"Eagle","year":"1955","journal-title":"Science"},{"key":"10.1016\/j.cllc.2013.09.001_bib22","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/S0021-9258(17)30124-2","article-title":"Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells","volume":"254","author":"Reitzer","year":"1979","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cllc.2013.09.001_bib23","first-page":"326","article-title":"The role of glutamine in the oxidative metabolism of malignant cells","volume":"32","author":"Kovacevic","year":"1972","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2013.09.001_bib24","doi-asserted-by":"crossref","first-page":"86S","DOI":"10.1177\/0148607190014004101","article-title":"Total parenteral nutrition, glutamine, and tumor growth","volume":"14","author":"Fischer","year":"1990","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.cllc.2013.09.001_bib25","doi-asserted-by":"crossref","first-page":"G1062","DOI":"10.1152\/ajpgi.00031.2002","article-title":"Molecular and functional analysis of glutamine uptake in human hepatoma and liver-derived cells","volume":"283","author":"Bode","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.cllc.2013.09.001_bib26","first-page":"511","article-title":"Glutamine transport in isolated human hepatocytes and transformed liver cells","volume":"21","author":"Bode","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.cllc.2013.09.001_bib27","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/jcp.21044","article-title":"Acute L-glutamine deprivation compromises VEGF-a upregulation in A549\/8 human carcinoma cells","volume":"212","author":"Drogat","year":"2007","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.cllc.2013.09.001_bib28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/bjc.1987.133","article-title":"Cell cycle phase perturbations by 6-diazo-5-oxo-L-norleucine and acivicin in normal and neoplastic human cell lines","volume":"55","author":"Huber","year":"1987","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2013.09.001_bib29","first-page":"798","article-title":"Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium","volume":"46","author":"Brower","year":"1986","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2013.09.001_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1152\/physrev.1990.70.1.43","article-title":"Role of amino acid transport and countertransport in nutrition and metabolism","volume":"70","author":"Christensen","year":"1990","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cllc.2013.09.001_bib31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1177\/0148607192016006569","article-title":"How amino acids get into cells: mechanisms, models, menus, and mediators","volume":"16","author":"Souba","year":"1992","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.cllc.2013.09.001_bib32","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/jcp.1041220221","article-title":"Adaptive regulatory control of System A transport activity in a kidney epithelial cell line (MDCK) and in a transformed variant (MDCK-T1)","volume":"122","author":"Boerner","year":"1985","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.cllc.2013.09.001_bib33","first-page":"F1050","article-title":"Glutamine transport in submitochondrial particles","volume":"257","author":"Sastrasinh","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cllc.2013.09.001_bib34","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/bj2490443","article-title":"Amino acid metabolism in tumour-bearing mice","volume":"249","author":"Rivera","year":"1988","journal-title":"Biochem J"},{"key":"10.1016\/j.cllc.2013.09.001_bib35","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/0022-4804(88)90106-0","article-title":"Interorgan glutamine metabolism in the tumor-bearing rat","volume":"44","author":"Souba","year":"1988","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.cllc.2013.09.001_bib36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0960-7404(92)90031-F","article-title":"Mechanisms of accelerated hepatic glutamine efflux in the tumour-bearing rat","volume":"1","author":"Pacitti","year":"1992","journal-title":"Surg Oncol"},{"key":"10.1016\/j.cllc.2013.09.001_bib37","first-page":"669","article-title":"The proportionality of glutaminase content to growth rate and morphology of rat neoplasms","volume":"29","author":"Knox","year":"1969","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2013.09.001_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/0148607191015002159","article-title":"Tumor regulation of hepatic glutamine metabolism","volume":"15","author":"Chen","year":"1991","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.cllc.2013.09.001_bib39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0026-0495(89)90140-6","article-title":"Skeletal muscle glutamine transport, intramuscular glutamine concentration, and muscle-protein turnover","volume":"38","author":"Rennie","year":"1989","journal-title":"Metabolism"},{"key":"10.1016\/j.cllc.2013.09.001_bib40","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0022-4804(91)90208-4","article-title":"Selective stimulation of brush border glutamine transport in the tumor-bearing rat","volume":"50","author":"Salloum","year":"1991","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.cllc.2013.09.001_bib41","first-page":"G90","article-title":"Characterization of Na(+)-independent glutamine transport in rat liver","volume":"265","author":"Pacitti","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cllc.2013.09.001_bib42","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1172\/JCI116225","article-title":"Tumor necrosis factor stimulates amino acid transport in plasma membrane vesicles from rat liver","volume":"91","author":"Pacitti","year":"1993","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cllc.2013.09.001_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0889-8588(18)30457-X","article-title":"Mechanisms of cancer cachexia","volume":"5","author":"Langstein","year":"1991","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.cllc.2013.09.001_bib44","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.4161\/cbt.21348","article-title":"Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth","volume":"13","author":"van den Heuvel","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.cllc.2013.09.001_bib45","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.lungcan.2011.02.008","article-title":"A\u00a0metabolomic approach to lung cancer","volume":"74","author":"Hori","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2013.09.001_bib46","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s12072-010-9230-2","article-title":"Expression level of glutamine synthetase is increased in hepatocellular carcinoma and liver tissue with cirrhosis and chronic hepatitis B","volume":"5","author":"Long","year":"2011","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cllc.2013.09.001_bib47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1146\/annurev.nu.15.070195.001025","article-title":"Regulation of glutaminase activity and glutamine metabolism","volume":"15","author":"Curthoys","year":"1995","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.cllc.2013.09.001_bib48","first-page":"3831","article-title":"Nitrogen movement between host and tumor in mice inoculated with Ehrlich ascitic tumor cells","volume":"44","author":"Carrascosa","year":"1984","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2013.09.001_bib49","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","article-title":"Bidirectional transport of amino acids regulates mTOR and autophagy","volume":"136","author":"Nicklin","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.cllc.2013.09.001_bib50","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.prp.2008.02.003","article-title":"Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung","volume":"204","author":"Kaira","year":"2008","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.cllc.2013.09.001_bib51","first-page":"3775","article-title":"Relationship between LAT1 expression and response to platinum-based chemotherapy in non-small cell lung cancer patients with postoperative recurrence","volume":"31","author":"Kaira","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cllc.2013.09.001_bib52","first-page":"4819","article-title":"Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer","volume":"30","author":"Imai","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cllc.2013.09.001_bib53","first-page":"468","article-title":"LAT1 expression is closely associated with hypoxic markers and mTOR in resected non-small cell lung cancer","volume":"3","author":"Kaira","year":"2011","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.cllc.2013.09.001_bib54","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1158\/1078-0432.CCR-12-2334","article-title":"SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival","volume":"19","author":"Hassanein","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2013.09.001_bib55","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev.pharmtox.37.1.205","article-title":"Pharmacology and functions of metabotropic glutamate receptors","volume":"37","author":"Conn","year":"1997","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.cllc.2013.09.001_bib56","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.cellsig.2005.10.012","article-title":"Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1\/2 via PKCepsilon","volume":"18","author":"Marin","year":"2006","journal-title":"Cell Signal"},{"key":"10.1016\/j.cllc.2013.09.001_bib57","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1755-148X.2009.00648.x","article-title":"AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1)","volume":"23","author":"Shin","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.cllc.2013.09.001_bib58","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1158\/0008-5472.CAN-06-3665","article-title":"Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma","volume":"67","author":"Namkoong","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2013.09.001_bib59","doi-asserted-by":"crossref","first-page":"6372","DOI":"10.1073\/pnas.091113598","article-title":"Glutamate antagonists limit tumor growth","volume":"98","author":"Rzeski","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cllc.2013.09.001_bib60","doi-asserted-by":"crossref","first-page":"18782","DOI":"10.1073\/pnas.0810199105","article-title":"Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction","volume":"105","author":"Wise","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cllc.2013.09.001_bib61","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF00058052","article-title":"Expression of oncoproteins in primary human non-small cell lung cancer and incidence of metastases","volume":"11","author":"Volm","year":"1993","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.cllc.2013.09.001_bib62","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1126\/science.1193494","article-title":"The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes","volume":"330","author":"Levine","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.cllc.2013.09.001_bib63","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.cllc.2013.09.001_bib64","doi-asserted-by":"crossref","first-page":"8788","DOI":"10.1073\/pnas.1003428107","article-title":"Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity","volume":"107","author":"Weinberg","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cllc.2013.09.001_bib65","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.1158\/0008-5472.CAN-12-0736","article-title":"Temporal molecular and biological assessment of an erlotinib-resistant lung adenocarcinoma model reveals markers of tumor progression and treatment response","volume":"72","author":"Weaver","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2013.09.001_bib66","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1093\/carcin\/bgh226","article-title":"Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions","volume":"25","author":"Balsara","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cllc.2013.09.001_bib67","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSC1-TSC2 complex: a molecular switchboard controlling cell growth","volume":"412","author":"Huang","year":"2008","journal-title":"Biochem J"},{"key":"10.1016\/j.cllc.2013.09.001_bib68","doi-asserted-by":"crossref","first-page":"14484","DOI":"10.1074\/jbc.273.23.14484","article-title":"Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism","volume":"273","author":"Hara","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cllc.2013.09.001_bib69","first-page":"132","article-title":"Pathological features of glutaminase toxicity","volume":"61","author":"Baskerville","year":"1980","journal-title":"Br J Exp Pathol"},{"key":"10.1016\/j.cllc.2013.09.001_bib70","doi-asserted-by":"crossref","first-page":"TPS3112","DOI":"10.1200\/jco.2012.30.15_suppl.tps3112","article-title":"A\u00a0phase I trial of riluzole and sorafenib in patients with advanced solid tumors and melanoma","volume":"30","author":"Mehnert","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2013.09.001_bib71","doi-asserted-by":"crossref","first-page":"TPS309","DOI":"10.1200\/jco.2010.28.15_suppl.tps309","article-title":"A\u00a0phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in metastatic melanoma","volume":"28","author":"Mehnert","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2013.09.001_bib72","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1158\/1078-0432.CCR-08-3303","article-title":"A\u00a0phase 0 trial of riluzole in patients with resectable stage III and IV melanoma","volume":"15","author":"Yip","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2013.09.001_bib73","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1200\/jco.2011.29.15_suppl.3049","article-title":"A\u00a0phase I schedule optimization study of pegylated glutaminase (PEG-PGA) plus 6-diazo-5-oxo-l-norleucine (DON) in patients (pts) with advanced solid tumors","volume":"29","author":"Unger","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2013.09.001_bib74","doi-asserted-by":"crossref","first-page":"14040","DOI":"10.1200\/jco.2007.25.18_suppl.14040","article-title":"A\u00a0phase I trial of PEGylated glutaminase (PEG-PGA) in combination with 6-diazo-5-oxo-L-norleucine (DON) in advanced, refractory, solid tumors","volume":"25","author":"Mueller","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2013.09.001_bib75","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1200\/jco.2008.26.15_suppl.2533","article-title":"A\u00a0phase IIa study of PEGylated glutaminase (PEG-PGA) plus 6-diazo-5-oxo-L-norleucine (DON) in patients with advanced refractory solid tumors","volume":"26","author":"Mueller","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2013.09.001_bib76","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1200\/jco.2004.22.90140.3183","article-title":"Glutaminase (PEG-PGA) increases antitumoral efficacy of cytotoxic agents","volume":"22","author":"Harzmann","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2013.09.001_bib77","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1111\/j.1349-7006.2009.01187.x","article-title":"Novel spliced form of a lens protein as a novel lung cancer antigen, Lengsin splicing variant 4","volume":"100","author":"Nakatsugawa","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.cllc.2013.09.001_bib78","first-page":"1041","article-title":"Identification of an HLA-A*0201-restricted cytotoxic T lymphocyte epitope from the lung carcinoma antigen, Lengsin","volume":"39","author":"Nakatsugawa","year":"2011","journal-title":"Int J Oncol"},{"key":"10.1016\/j.cllc.2013.09.001_bib79","first-page":"1031","article-title":"Phase II evaluation of acivicin in lung cancer: a Southeastern Cancer Study Group Trial","volume":"70","author":"Kramer","year":"1986","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.cllc.2013.09.001_bib80","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00000421-199406000-00006","article-title":"Phase II trial of acivicin versus etoposide-cisplatin in non-small cell lung cancer. An Eastern Cooperative Oncology Group study","volume":"17","author":"Bonomi","year":"1994","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.cllc.2013.09.001_bib81","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/cncr.24957","article-title":"Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas","volume":"116","author":"Iwamoto","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2013.09.001_bib82","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1158\/1535-7163.MCT-11-0942","article-title":"Dibenzophenanthridines as inhibitors of glutaminase C and cancer cell proliferation","volume":"11","author":"Katt","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.cllc.2013.09.001_bib83","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.2967\/jnumed.111.093815","article-title":"PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine","volume":"52","author":"Lieberman","year":"2011","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cllc.2013.09.001_bib84","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2967\/jnumed.111.093831","article-title":"Preparation and characterization of L-[5-11C]-glutamine for metabolic imaging of tumors","volume":"53","author":"Qu","year":"2012","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cllc.2013.09.001_bib85","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0163-7258(90)90094-I","article-title":"Metabolism and action of amino acid analog anti-cancer agents","volume":"46","author":"Ahluwalia","year":"1990","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cllc.2013.09.001_bib86","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/bjc.1998.23","article-title":"Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas","volume":"77","author":"Suwa","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2013.09.001_bib87","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1073\/pnas.97.1.185","article-title":"Endogenous, hyperactive Rac3 controls proliferation of breast cancer cells by a p21-activated kinase-dependent pathway","volume":"97","author":"Mira","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cllc.2013.09.001_bib88","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ccr.2010.08.009","article-title":"Targeting mitochondrial glutaminase activity inhibits oncogenic transformation","volume":"18","author":"Wang","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cllc.2013.09.001_bib89","doi-asserted-by":"crossref","first-page":"734","DOI":"10.18632\/oncotarget.208","article-title":"Glutaminase: a hot spot for regulation of cancer cell metabolism?","volume":"1","author":"Erickson","year":"2010","journal-title":"Oncotarget"},{"key":"10.1016\/j.cllc.2013.09.001_bib90","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/0971-5851.96962","article-title":"Glutamine: a novel approach to chemotherapy-induced toxicity","volume":"33","author":"Gaurav","year":"2012","journal-title":"Indian J Med Paediatr Oncol"},{"key":"10.1016\/j.cllc.2013.09.001_bib91","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/978-3-642-81488-4_30","article-title":"The rediscovery of DON (6-diazo-5-oxo-L-norleucine)","volume":"74","author":"Kisner","year":"1980","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.cllc.2013.09.001_bib92","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0065-2571(94)90009-4","article-title":"Targeted and non-targeted actions of anti-cancer drugs","volume":"34","author":"Weber","year":"1994","journal-title":"Adv Enzyme Regul"},{"key":"10.1016\/j.cllc.2013.09.001_bib93","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/ijc.25431","article-title":"Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model","volume":"127","author":"Shelton","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cllc.2013.09.001_bib94","first-page":"3220","article-title":"Efficacy of 6-diazo-5-oxo-L-norleucine and N-[N-gamma-glutamyl-6-diazo-5-oxo-norleucinyl]-6-diazo-5-oxo-norleucine against experimental tumors in conventional and nude mice","volume":"39","author":"Ovejera","year":"1979","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2013.09.001_bib95","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1182\/blood.V74.5.1728.1728","article-title":"Monocytoid differentiation of freshly isolated human myeloid leukemia cells and HL-60 cells induced by the glutamine antagonist acivicin","volume":"74","author":"Nichols","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.cllc.2013.09.001_bib96","first-page":"1121","article-title":"Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada study","volume":"68","author":"Maroun","year":"1984","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.cllc.2013.09.001_bib97","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/sj.bjc.6602978","article-title":"Targeted therapy for metastatic renal cell carcinoma","volume":"94","author":"Patel","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2013.09.001_bib98","doi-asserted-by":"crossref","first-page":"8981","DOI":"10.1158\/0008-5472.CAN-10-1666","article-title":"Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1","volume":"70","author":"Seltzer","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2013.09.001_bib99","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.lungcan.2008.06.015","article-title":"Prevention of acute radiation-induced esophagitis with glutamine in non-small cell lung cancer patients treated with radiotherapy: evaluation of clinical and dosimetric parameters","volume":"63","author":"Topkan","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2013.09.001_bib100","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/1471-2407-12-502","article-title":"Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer","volume":"12","author":"Topkan","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cllc.2013.09.001_bib101","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2967\/jnumed.110.084244","article-title":"Role of glutamine in cancer: therapeutic and imaging implications","volume":"52","author":"Rajagopalan","year":"2011","journal-title":"J\u00a0Nucl Med"},{"issue":"suppl 2","key":"10.1016\/j.cllc.2013.09.001_bib102","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.2967\/jnumed.108.053751","article-title":"Molecualr imaging of cancer: from molecules to humans. Introduction","volume":"49","author":"Gambhir","year":"2008","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cllc.2013.09.001_bib103","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.semcdb.2012.02.002","article-title":"Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis","volume":"23","author":"Daye","year":"2012","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.cllc.2013.09.001_bib104","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1021\/ja109203d","article-title":"Synthesis of optically pure 4-fluoro-glutamines as\u00a0potential metabolic imaging agents for tumors","volume":"133","author":"Qu","year":"2011","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.cllc.2013.09.001_bib105","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.2967\/jnumed.111.101279","article-title":"Comparative evaluation of 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents","volume":"53","author":"Ploessl","year":"2012","journal-title":"J\u00a0Clin Nucl Med"},{"key":"10.1016\/j.cllc.2013.09.001_bib106","doi-asserted-by":"crossref","first-page":"19345","DOI":"10.1073\/pnas.0709747104","article-title":"Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis","volume":"104","author":"DeBerardinis","year":"2007","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730413002210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730413002210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:04:02Z","timestamp":1761505442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730413002210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":106,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1525730413002210"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2013.09.001","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered Glutamine Metabolism and Therapeutic Opportunities for Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2013.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}